Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 1243 Name frontpro
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
FRONTPRO 68 mg EU/2/19/240/012 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs >10–25 kg

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/012 68 mg 15 PVH/Aclar/Al blisteris, 1 tablete -
FRONTPRO 68 mg EU/2/19/240/011 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs >10–25 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/011 68 mg 1 PVH/Aclar/Al blisteris, 6 tablete -
FRONTPRO 136 mg EU/2/19/240/016 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs >25–50 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/016 136 mg 15 PVH/Aclar/Al blisteris, 1 tablete -
FRONTPRO 28.3 mg EU/2/19/240/008 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs >4–10 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/008 28,3 mg 15 PVH/Aclar/Al blisteris, 1 tablete -
FRONTPRO 11.3 mg EU/2/19/240/002 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs 2–4 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/002 11,3 mg 1 PVH/Aclar/Al blisteris, 3 tablete -
FRONTPRO 28.3 mg EU/2/19/240/006 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs >4–10 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/006 28,3 mg 1 PVH/Aclar/Al blisteris, 3 tablete -
FRONTPRO 136 mg EU/2/19/240/014 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs >25–50 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/014 136 mg 1 PVH/Aclar/Al blisteris, 3 tablete -
FRONTPRO 11.3 mg EU/2/19/240/004 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs 2–4 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/004 11,3 mg 15 PVH/Aclar/Al blisteris, 1 tablete -
FRONTPRO 68 mg EU/2/19/240/009 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs >10–25 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/009 68 mg 1 PVH/Aclar/Al blisteris, 1 tablete -
FRONTPRO 136 mg EU/2/19/240/015 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs >25–50 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/015 136 mg 1 PVH/Aclar/Al blisteris, 6 tablete -
FRONTPRO 68 mg EU/2/19/240/010 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs >10–25 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/010 68 mg 1 PVH/Aclar/Al blisteris, 3 tablete -
FRONTPRO 136 mg EU/2/19/240/013 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs >25–50 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/013 136 mg 1 PVH/Aclar/Al blisteris, 1 tablete -
FRONTPRO 11.3 mg EU/2/19/240/003 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs 2–4 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/003 11,3 mg 1 PVH/Aclar/Al blisteris, 6 tablete -
FRONTPRO 28.3 mg EU/2/19/240/005 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs >4–10 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/005 28,3 mg 1 PVH/Aclar/Al blisteris, 1 tablete -
FRONTPRO 11.3 mg EU/2/19/240/001 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs 2–4 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/001 11,3 mg 1 PVH/Aclar/Al blisteris, 1 tablete -
FRONTPRO 28.3 mg EU/2/19/240/007 Boehringer Ingelheim Vetmedica GmbH, Vācija QP53BE01 Dogs >4–10 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Afoxolaner
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Merial, Francija
Date of authorisation/renewal: 20-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/19/240/007 28,3 mg 1 PVH/Aclar/Al blisteris, 6 tablete -

16 records · Download

  • 1
© Food and veterinary service · 2026 Cookies policy